Nectar Life drops on selling core pharma service to Ceph Lifesciences for Rs 1,270 Cr
INSUBCONTINENT EXCLUSIVE:
Nectar Lifesciences plunged 17.75% to Rs 19.05 after the company announced a major strategic move, selling its core business division to
Ceph Lifesciences for Rs 1,270 crore.
